GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
3.360
+0.110 (3.38%)
Oct 8, 2026, 4:00 PM EDT - Market closed
GoodRx Holdings Revenue
GoodRx Holdings had revenue of $200.41M in the quarter ending June 30, 2026, a decrease of -1.31%. This brings the company's revenue in the last twelve months to $785.23M, down -1.83% year-over-year. In the year 2025, GoodRx Holdings had annual revenue of $796.85M with 0.57% growth. That makes GoodRx Holdings the 8,757th largest company in the world by revenue and 1,960th in the United States.
Revenue (ttm)
$785.23M
Revenue Growth
-1.83%
P/S Ratio
1.46
Revenue / Employee
$1,126,585
Employees
697
Market Cap
1.15B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 796.85M | 4.53M | 0.57% |
| Dec 31, 2024 | 792.32M | 42.06M | 5.61% |
| Dec 31, 2023 | 750.27M | -16.29M | -2.12% |
| Dec 31, 2022 | 766.55M | 21.13M | 2.83% |
| Dec 31, 2021 | 745.42M | 194.72M | 35.36% |
| Dec 31, 2020 | 550.70M | 162.48M | 41.85% |
| Dec 31, 2019 | 388.22M | 138.70M | 55.59% |
| Dec 31, 2018 | 249.52M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.49B |
| Privia Health Group | 2.36B |
| Omnicell | 1.25B |
| Phreesia | 507.79M |
| Certara | 421.75M |
| HealthStream | 321.12M |
| Omada Health | 309.76M |
| Schrödinger | 259.04M |
GDRX News
- 9 days ago - Amazon, GoodRx target US prescription subscribers as health insurance coverage slips - Reuters
- 4 weeks ago - GoodRx Covers Whole Households and Pets in New Prescription Plan - PYMNTS
- 5 weeks ago - GoodRx launches Companion Family Plan - TheFly
- 5 weeks ago - GoodRx offers health subscription for families, to launch as employee benefit in 2027 - Reuters
- 5 weeks ago - From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household - Business Wire
- 7 weeks ago - GoodRx price target raised to $4 from $3 at Barclays - TheFly
- 7 weeks ago - GoodRx price target raised to $3.75 from $2.50 at UBS - TheFly
- 1 month ago - GoodRx price target raised to $5 from $4 at TD Cowen - TheFly